Aquest announces three-pronged initiative to foster racial equality and social justice
Company educates staff on social justice, ensures they have time to vote, and makes financial commitment to NAACP Legal Defense and Educational Fund. In a proactive effort to support the ongoing fight to end racial injustice, Aquent, the world’s largest marketing and creative staffing firm, today announced a set of company-wide initiatives designed to foster racial equality. First, the company will promote two important books by authors of color to help educate staff on the history and purpose of this [...]
The Greater Boston Convention & Visitors Bureau Partners with Allen & Gerritsen to Create Homegrown Tourism Video
Allen & Gerritsen (A&G) and The Greater Boston Convention & Visitors Bureau (GBCVB) – the not-for-profit organization promoting tourism and visitation to Boston, Cambridge and the surrounding metropolitan area – premiered a video featuring the sights and sounds of the city to remind local residents why Boston is and always will be home. Click here to read full press release.
Packaging Technology Group (PTG) Expands National Footprint with Opening of New Louisville, Kentucky Location
June 9, 2020 – Greater Boston, MA and Louisville, KY- Packaging Technology Group, Inc., (PTG), a leading provider of thermalpackaging solutions for the biopharmaceutical and life sciences sector,announced today the opening of a new location in Louisville, Kentucky. Thenewly constructed facility, called PTG Kentucky, is located at 1001 GlengarryDrive, Fairdale, KY. Click here to read full press release.
Safety 1st Partners with Allen & Gerritsen to Create “Signs of the Times” for Parents Working From Home
Allen & Gerritsen (A&G) and Safety 1st, a leading provider of child safety products, today unveiled “Signs of the Times,” a creative campaign rooted in empathy and humor that has refreshed the brand’s iconic “Baby on Board” sign for parents working from home during the novel coronavirus (COVID-19) pandemic. Created by parents, for parents, the campaign assets include both video and static backgrounds for virtual meetings, as well as Instagram stickers and GIFs. Click here to read full press release.
Home Use of GENOSYL® Delivery System (DS) to Administer GENOSYL® (nitric oxide) gas for Inhalation for the Treatment of Pulmonary Hypertension Complicated by COVID-19 Infection Published in American Journal of Respiratory and Critical Care Medicine
Clinicians report on first at-home treatment of COVID-19 patient with VERO Biotech’s GENOSYL DS, an innovative, tankless delivery system for inhaled nitric oxide. Click here to read full press release.
Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals
VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that it is doubling down on its commitment to support the treatment of patients afflicted with complications of COVID with GENOSYL® DS, the first and only FDA-approved tankless system for the delivery of inhaled nitric oxide. Click here to read full press release.
FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1. Click here for full press release
VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
Treatment informs FDA approval for emergency expanded access use for GENOSYL® inhaled nitric oxide. Click here to read full press release